Venture Visionary Partners LLC Purchases 9,301 Shares of Sabra Healthcare REIT, Inc. $SBRA

Venture Visionary Partners LLC grew its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report) by 8.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 116,821 shares of the real estate investment trust’s stock after purchasing an additional 9,301 shares during the quarter. Venture Visionary Partners LLC’s holdings in Sabra Healthcare REIT were worth $2,041,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. UMB Bank n.a. raised its position in shares of Sabra Healthcare REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock valued at $36,000 after purchasing an additional 1,621 shares during the period. Assetmark Inc. raised its position in shares of Sabra Healthcare REIT by 37.8% in the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust’s stock valued at $63,000 after purchasing an additional 989 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Sabra Healthcare REIT in the first quarter valued at approximately $63,000. Fifth Third Bancorp raised its position in shares of Sabra Healthcare REIT by 110.3% in the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust’s stock valued at $67,000 after purchasing an additional 2,011 shares during the period. Finally, GF Fund Management CO. LTD. bought a new position in shares of Sabra Healthcare REIT in the fourth quarter valued at approximately $74,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Up 1.5%

Shares of Sabra Healthcare REIT stock opened at $18.91 on Wednesday. The company’s fifty day simple moving average is $18.37 and its 200-day simple moving average is $17.64. The company has a market cap of $4.53 billion, a price-to-earnings ratio of 24.88, a PEG ratio of 1.54 and a beta of 0.86. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last announced its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.02. The business had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. Sabra Healthcare REIT’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the company posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.3%. Sabra Healthcare REIT’s payout ratio is currently 157.89%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Scotiabank raised their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research note on Monday, June 23rd. JMP Securities raised their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Sabra Healthcare REIT currently has an average rating of “Moderate Buy” and an average target price of $20.00.

View Our Latest Research Report on SBRA

Sabra Healthcare REIT Company Profile

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Read More

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.